Precision Medicine
First integrated system to demonstrate improved clinical outcomes in oncology using live patient tissue and the power of AI
Testing directly on viable human tissue, we also analyse data at the single cell level. In the landmark EXALT-1 clinical study, our platform demonstrated for the first time that functional precision-oncology can improve patient outcome in a prospective interventional trial. Find out more on this page.
Human Tissue
Interrogating activities directly in viable human tissue samples allows us to generate deep, clinically relevant insights into which molecules will deliver the most treatment benefit.
Single Cell
Exploring response at single cell resolution allows us to even distinguish on-target from off-target response in complex tissues
AI Analysis
Powered by AI, for the benefit of the patient, we are pioneering new approaches in precision medicine, demonstrating for the first time that functional precision-oncology can improve patient outcome in a prospective interventional trial.
EXALT-1: Clinical Trial
In the landmark study, it was demonstrated for the first time that our functional precision-oncology platform can improve patient outcome in a prospective interventional trial.
EXALT-1

Progression Free Survival
